High-throughput discovery of inhibitory protein fragments with AlphaFold
Proceedings of the National Academy of Sciences · 11.02.2025 · 122 (6)
DOI: 10.1073/pnas.2322412122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.02.2025. Verfasst von Andrew Savinov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139. Hauptthemen laut MEDLINE: Peptide Fragments, Computational Biology, High-Throughput Screening Assays, Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH.
Abstract (Originalsprache)
Peptides can bind to specific sites on larger proteins and thereby function as inhibitors and regulatory elements. Peptide fragments of larger proteins are particularly attractive for achieving these functions due to their inherent potential to form native-like binding interactions. Recently developed experimental approaches allow for high-throughput measurement of protein fragment inhibitory activity in living cells. However, it has thus far not been possible to predict de novo which of the many possible protein fragments bind to protein targets, let alone act as inhibitors. We have developed a computational method, FragFold, that employs AlphaFold to predict protein fragment binding to full-length proteins in a high-throughput manner. Applying FragFold to thousands of fragments tiling across diverse proteins revealed peaks of predicted binding along each protein sequence. Comparisons with experimental measurements establish that our approach is a sensitive predictor of fragment function: Evaluating inhibitory fragments from known protein–protein interaction interfaces, we find 87% are predicted by FragFold to bind in a native-like mode. Across full protein sequences, 68% of FragFold-predicted binding peaks match experimentally measured inhibitory peaks. Deep mutational scanning experiments support the predicted binding modes and uncover superior inhibitory peptides in high throughput. Further, FragFold is able to predict previously unknown protein binding modes, explaining prior genetic and biochemical data. The success rate of FragFold demonstrates that this computational approach should be broadly applicable for discovering inhibitory protein fragments across proteomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
- Koch Center for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
- HHMI, Massachusetts Institute of Technology, Cambridge, MA 02139.
ORCID-Profile: Andrew Savinov, Amy E Keating, Gene-Wei Li
Förderung
- NIGMS NIH HHS
- HHS | NIH
Zitieren
APA
Savinov, A., Swanson, S., Keating, A. E., & Li, G. W. (2025). High-throughput discovery of inhibitory protein fragments with AlphaFold. Proceedings of the National Academy of Sciences, 122(6). https://doi.org/10.1073/pnas.2322412122
Vancouver
Savinov A, Swanson S, Keating AE, Li GW. High-throughput discovery of inhibitory protein fragments with AlphaFold. Proceedings of the National Academy of Sciences. 2025;122(6). doi:10.1073/pnas.2322412122
BibTeX
@article{Savinov2025,
author = {Savinov, Andrew and Swanson, Sebastian and Keating, Amy E and Li, Gene-Wei},
title = {High-throughput discovery of inhibitory protein fragments with AlphaFold},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {6},
doi = {10.1073/pnas.2322412122}
}
EUVIMED